Last reviewed · How we verify

NCT05526105

Gastric US in ICU Patient

Recruiting now NA Last updated 27 June 2024
What this trial tests

NA trial testing Gastric Ultrasound in Critical Illness in 50 participants. Currently enrolling.

Timeline
3 February 2023
Primary endpoint
3 February 2025
3 February 2025

Quick facts

Lead sponsorDartmouth-Hitchcock Medical Center
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposescreening
Enrollment50
Start date3 February 2023
Primary completion3 February 2025
Estimated completion3 February 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Dartmouth-Hitchcock Medical Center

Who can join

Adults 18 to 100, any sex, with Critical Illness or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a case series study using gastric ultrasound in critically ill patients to quantify gastric residual volumes to compare the efficacy of different NPO protocols.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Gastric Ultrasound

Trials testing the same drug.

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Other Dartmouth-Hitchcock Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05526105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing